HPV vaccine in the treatment of usual type vulval and vaginal intraepithelial neoplasia: a systematic review.
Stacey J BryanCynthia BarbaraJane ThomasAdeola OlaitanPublished in: BMC women's health (2019)
This review finds the evidence relating to the use of HPV vaccine in the treatment of women with VIN/VaIN is of very low quality and insufficient to guide practice. Further longitudinal studies are needed to assess its use in prevention of progression to cancer.